Topics

vaccine composition

The manner in which the parts of a vaccine are combined or related.

vaccines
2.4 Nonclinical Overview AZD1222
2.5 Clinical Overview: AZD1222 Marketing Authorisation Application - Primary Analysis (Data Cut-off 07 December 2020)
A cautionary note: Toxicity of polyethylene glycol 200 injected intraperitoneally into mice
A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables
A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy
A rapid detection method of replication-competent plasmid DNA from COVID-19 mRNA vaccines for quality control
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID-19 “mRNA Vaccines"
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR)
Assessment report: COVID-19 Vaccine Moderna
At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with PreciseICP-MS1
BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence
Cationic compounds used in lipoplexes and polyplexes for gene delivery
CAUGHT ON CAMERA: W.H.O SCIENTISTS QUESTION SAFETY OF VACCINES
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 - A Multidisciplinary Perspective
Chemical-physical criticality and toxicological potential of lipid nanomaterials contained in a COVID-19 mRNA vaccine
Comirnaty Facts: Mechanisms of action and damage potential
Confirmation of the presence of vaccine DNA in the Pfizer anti-COVID-19 vaccine
Congressional-hearing statement of Dr. Robert Malone on the presence of DNA in mRNA vaccines
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 mRNA vaccines contain excessive quantities of bacterial DNA: evidence and implications
Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
Dark-Field Microscopic Analysis on the Blood of 1,006 Symptomatic Persons After Anti-COVID mRNA Injections from Pfizer/BioNtech or Moderna
DNA Contamination Study — Conducted at FDA Lab by Students Supervised by FDA Scientists — ‘Doesn’t Belong to FDA’ Agency Says
Emergence of a New Creutzfeldt-Jakob Disease: 26 Cases of the Human Version of Mad-Cow Disease, Days After a COVID-19 Inj
First case of postmortem study in a patient vaccinated against SARS-CoV-2
Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines
For “Such a Time as This”
Form S-1 Registration Statement Under the Securities Act of 1933: BioNTech SE
Form S-1 Registration Statement Under the Securities Act of 1933: Moderna, Inc.
Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity
Graphene and graphene oxide as nanomaterials for medicine and biology application
Graphene and the Immune System: A Romance of Many Dimensions
How Bad is My Batch? Batch codes and associated deaths, disabilities and illnesses for Covid 19 Vaccines
If Not Now, When?
Injections from Hell?
Investigation of metallic contaminations found in vector- and mRNA-based COVID-19-”vaccines”: Preliminary Results
Long Term Follow-Up After Administration of Human Gene Therapy Products Guidance for Industry
Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty®
mRNA Platform: Enabling Drug Discovery & Development
mRNA, Nanolipid Particles and PEG: A Triad Never Used in Clinical Vaccines is Going to Be Tested on Hundreds of Millions of People
Nanotechnology: Self Assembly Structures in mRNA-Injections
No Nanobots in Vaccines — Just Lipids on the Loose
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Panel of doctors in Nashville, Tennessee
Pfizer DNA Detected in Colon Cancer Biopsy: Kevin McKernan Presents Findings
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
1470